We serve more than 80 countries globally, over 300 staff within manufacturing, commercial quality in our 2 manufacturing plants. These are strategically located in China, Korea.
Our site in China is focused on our injectable fillers. Our Korea site is focused in botulinum toxin type A.

Our operations embrace the most advanced manufacturing technologies to enable innovation at scale and support the rapid growth of our business. We work in an integrated way across the organization to deliver products to customers in a fast, flexible and reliable manner.

Safety and quality are essential pillars of our business conduct, and key to our long-trusted relationships with patients, dermatologists and aesthetic practitioners. Our quality and manufacturing processes adhere to local and global laws and regulations.
We measure and monitor patient safety and consumer satisfaction and implement policies and procedures to ensure compliance with applicable regulations.

All of our sites are regularly audited by health authorities (e.g., the Chinese Food and Drug Administration (CFDA), the Korea Food and Drug Administration (KFDA). In addition, we have earned multiple certifications for all our manufacturing sites, including ISO CE. These certifications demonstrate a commitment to environmental, health and safety management systems.